Fig. 6

Survival analysis of RPLP2 in HCC. A–C Kaplan–Meier curves for patient’s OS (A), DSS (B) or PFI (C) classified by different expression level of RPLP2 in HCC (n of low = 187, n of high = 186). D–N Kaplan–Meier curves indicating the OS prognostic value of RPLP2 expression in different HCC subgroups including, T1 and T2 (D) (n of low = 139, n of high = 138), T3 and T4 (E) (n of low = 46, n of high = 47), N0 (F) (n of low = 127, n of high = 127), M0 (G) (n of low = 134, n of high = 134), Stage III and IV (H) (n of low = 45, n of high = 45), tumor free (I) (n of low = 101, n of high = 101), age ≤ 60 (J) (n of low = 88, n of high = 89), hepatocellular carcinoma (K) (n of low = 182, n of high = 181), R0 (L) (n of low = 163, n of high = 163), G3 and G4 (M) (n of low = 68, n of high = 67) and Child–Pugh grade A (N) (n of low = 109, n of high = 109). O Forest plots showing the potential prognostic indicators for OS. (The data was obtained from TCGA-LIHC)